The Net Margin of Xbrane Biopharma AB (XBRANE.ST) is -133.97%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -133.97% |
| 2023-12-31 | -162.60% |
| 2022-12-31 | -299.41% |
| 2021-12-31 | -64.61% |
| 2020-12-31 | -216.34% |
| 2019-12-31 | -3015.02% |